William Blair initiates coverage of digital finance stocks

Equities research analysts at William Blair dropped their Q4 2025 EPS estimates for Zumiez in a research report issued on ...
"It is my pleasure to welcome Terence to William Blair’s Healthcare investment banking practice and its biopharma group," said Steve Tole, head of Healthcare investment banking at William Blair. "Our ...
William Blair International Growth Fund earns an Average Process Pillar rating. The most important driver of the rating is the stability of the management team. Specifically, the fund has not seen ...
Research analysts at William Blair boosted their FY2025 EPS estimates for shares of Exelixis in a research report issued on ...
William Blair initiated coverage of Elevation Oncology (ELEV) with an Outperform rating without a price target The shares offer “high potential reward for a relatively low upfront investment ...
William Blair Small Cap Growth Fund earns an Average Process Pillar rating. The leading factor in the rating is the fund's excellent long-term risk-adjusted performance. This can be seen in its ...
Equities researchers at William Blair lifted their FY2024 earnings estimates for Shake Shack in a research report issued to ...